Financhill
Back

Recursion Pharmaceuticals Quote, Financials, Valuation and Earnings

Recursion Pharmaceuticals Price Quote

$5.80
-0.24 (-3.97%)
(Updated: November 21, 2024 at 12:20 PM ET)

Recursion Pharmaceuticals Key Stats

Sell
48
Recursion Pharmaceuticals (RXRX) is a Sell

Day range:
$5.70 - $6.37
52-week range:
$5.89 - $15.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
23.20
P/B ratio:
3.33%

Volume:
16.2M
Avg. volume:
5.9M
1-year change:
-11.95%
Market cap:
$1.7B
Revenue:
$43.9M
EPS:
$-1.55

How Much Does Recursion Pharmaceuticals Make?

Is Recursion Pharmaceuticals Growing As A Company?

Recursion Pharmaceuticals Stock Price Performance

What Is Recursion Pharmaceuticals 52-Week High & Low?

Recursion Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Recursion Pharmaceuticals?

Is Recursion Pharmaceuticals Cash Flow Positive?

  • What Is RXRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$317.8M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $374.1M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$17.9M

Recursion Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RXRX return on invested capital is -76.3%
  • What Is Recursion Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -56.47%
  • What Is RXRX Return On Equity?
    ROE is a measure of profitability and is -78.32%

Recursion Pharmaceuticals Earnings Date & Stock Price

Recursion Pharmaceuticals Competitors

Recursion Pharmaceuticals Dividend Yield

Recursion Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.15%
Revenue: 158.19% -12.56%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 9.86
Upside from Last Price: 63.2%

Major Shareholders

  • How many RXRX shares are owned by institutional investors?
    389.7M RXRX shares are owned by institutional investors
  • How many RXRX shares are owned by insiders?
    11.2M RXRX shares are owned by insiders